Life SciencesMedical DevicesMinimally Invasive Surgery

Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook (2018-2022)

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $800 91 Pages Koncept Analytics March, 2018 KOAN15622923
Lowest Prices Guaranteed
Price from $800
Length 91 Pages
Publisher Koncept Analytics
Published Date March, 2018
SKU KOAN15622923

Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook (2018-2022)

Transcatheter aortic valve implantation (TAVI) is a relatively new technology in the field of medical science. It is a minimally invasive surgery of replacing heart valve without undergoing the conventional by-pass surgery. It has emerged as one of the most feasible alternatives to conventional surgical aortic valve replacement. Transcatheter aortic valve implantation is also sometimes called as Transcatheter Aortic Valve Replacement (TAVR). The transcatheter aortic valve replacement market has gained popularity as a treatment option for those who are too weak to undergo surgery or are at high risk.

There are multiple approaches for TAVI procedure which includes transfemoral, transapical and transaortic approach. TAVI uses a catheter to replace the heart valve instead of the opening of the chest and completely removing the diseased valve. The TAVI valve is implanted within the diseased aortic valve. The valve is compressed onto the balloon that is expanded, pushing the leaflets of the diseased valve outside and when balloon deflated, the valve begins working instantly. This technique is still in its early stages but is growing rapidly through observational studies and randomized clinical trials.

The global TAVI market is expected to grow in future due to increasing ageing population, rising healthcare expenditure, increasing obese population, global economic development and increasing prevalence of inoperable aortic stenosis. Key trends in this market include rising demand for minimally invasive procedures, strong research and development efforts, rising mergers, technological advancements, favorable reimbursement policies, new product launch and TAVI for low-risk patients. However, the growth of this market will be hindered by stringent regulations, high cost of TAVI devices and high risks associated with the TAVI procedure.

The report “Global TAVI Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market, with focus on the U.S and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Edwards Lifesciences, Boston Scientific, Medtronic Plc. and Abbott Laboratories are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global TAVI market along with the study of the regional markets.


1. Market Overview
1.1 Aortic Stenosis
1.2 Transcatheter Aortic Valve Implantation (TAVI)
1.3 TAVI Procedure
Table 1: Approaches to TAVI Procedure
1.4 Approaches to TAVI Procedure
1.5 Benefits and Risk Associated with TAVI Procedure
2. Global Market Analysis
2.1 Global TAVI Market by Value
Table 2: Global TAVI Market by Value (2013-2017)
2.2 Global TAVI Market Forecast by Value
Table 3: Global TAVI Market Forecast by Value (2018-2022)
2.3 Global TAVI Implant Volume
Table 4: Global TAVI Implant Volume (2013-2017)
2.4 Global TAVI Implant Volume Forecast
Table 5: Global TAVI Implant Volume Forecast (2018-2022)
2.5 Global TAVI Patient Population
Table 6: Global TAVI Patient Population (2013-2017)
2.6 Global TAVI Patient Population Forecast
Table 7: Global TAVI Patient Population Forecast (2018-2022)
2.7 TAVI Market by Region
Table 8: TAVI Market by Region (2017)
3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. TAVI Market by Value
Table 9: The U.S. TAVI Market by Value (2013-2017)
3.1.2 The U.S. TAVI Market Forecast by Value
Table 10: The U.S. TAVI Market Forecast by Value (2018-2022)
3.1.3 The U.S. TAVI Implant Volume
Table 11: The U.S. TAVI Implant Volume (2013-2017)
3.1.4 The U.S. TAVI Implant Volume Forecast
Table 12: The U.S. TAVI Implant Volume Forecast (2018-2022)
3.1.5 The U.S. TAVI Implant Volume by Patient Type
Table 13: The U.S. TAVI Implant Volume by Patient Type (2017)
3.1.6 The U.S. TAVI Implant Volume Forecast- Patient Type
Table 14: The U.S. TAVI Implant Volume Forecast- Patient Type (2018-2022)
3.1.7 The U.S. TAVI Implant Volume by Access Route
Table 15: The U.S. TAVI Implant Volume by Access Route (2017)
3.1.8 The U.S. Aortic Valve Disease Patient Population Forecast
Table 16: The U.S. Aortic Valve Disease Patient Population Forecast (2017-2022)
3.2 Outside the U.S.
3.2.1 OUS TAVI Market by Value
Table 17: OUS TAVI Market by Value (2013-2017)
3.2.2 OUS TAVI Market Forecast by Value
Table 18: OUS TAVI Market Forecast by Value (2018-2022)
3.2.3 OUS TAVI Implant Volume
Table 19: OUS TAVI Implant Volume (2013-2017)
3.2.4 OUS TAVI Implant Forecast by Volume
Table 20: OUS TAVI Implant Forecast by Volume (2018-2022)
3.2.5 OUS TAVI Patient Population
Table 21: OUS TAVI Patient Population (2013-2017)
3.2.6 OUS TAVI Patient Population Forecast
Table 22: OUS TAVI Patient Population Forecast (2018-2022)
3.2.7 Europe TAVI Implant Volume by Patient Type
Table 23: Europe TAVI Implant Volume by Patient Type (2017)
3.2.8 Europe TAVI Implant Volume Forecast by Patient Type
Table 24: Europe TAVI Implant Volume Forecast by Patient Type (2018-2022)
3.2.9 Europe TAVI Implant Volume by Access Route
Table 25: Europe TAVI Implant Volume by Access Route (2017)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Ageing Population
Table 26: Global Ageing Population (2013-2017)
4.1.2 Escalating Healthcare Spending
Table 27: Global Healthcare Spending Per Capita (2013-2017)
4.1.3 Rising GDP Per Capita
Table 28: Global GDP Per Capita (2013-2017)
4.1.4 Increase in Obese Population
Table 29: Global Obese Population (2013-2017)
4.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
4.2 Key Trends & Development
4.2.1 Strong Research & Development Efforts by Companies
Table 30: R&D Expenditure of Companies (2017)
4.2.2 Rising Mergers and Acquisitions
Table 31: Mergers and Acquisitions (2017)
4.2.3 Growing Adoption of Minimally Invasive Therapies
4.2.4 Recent Technological Advancements
4.2.5 Burden of Cardiovascular Diseases in the U.S.
Table 32: Burden of Cardiovascular Diseases in the U.S. (2017)
4.2.6 Favorable Reimbursement Policies
4.2.7 TAVI for Low Risk Patients
4.2.8 New Product Launches
4.3 Challenges
4.3.1 Associated High Risk
4.3.2 Tough Regulatory Problems
4.3.3 High Cost Related to TAVI
5. Competition
5.1 Global Market
5.1.1 Revenue and Market Cap Comparison
Table 33: Key Players - Revenue & Market Cap Comparison (2017)
5.1.2 Global TAVI Market Share by Company
Table 34: Global TAVI Market Share by Company (2017/2022)
5.1.3 Global TAVI Market-Implanting Centers by Company
Table 35: Global TAVI Market- Implanting Centers by Company (2017-2022)
5.1.4 Global TAVI Market- Total Implants by Company
Table 36: Global TAVI Market- Total Implants by Company (2017-2022)
5.1.5 Global TAVI Market- Average Selling Price of Implants by Company
Table 37: Global TAVI Market- Average Selling Price of Implants by Company (2017-2022)
5.2 The U.S.
5.2.1 The U.S. TAVI Market Share by Company
Table 38: The U.S. TAVI Market Share by Company (2017/2022)
5.2.2 The U.S. TAVI Market-Implanting Centers by Company
Table 39: The U.S. TAVI Market-Implanting Centers by Company (2017-2022)
5.2.3 The U.S. TAVI Market-Total Implants by Company
Table 40: The U.S. TAVI Market-Total Implants by Company (2017-2022)
5.2.4 The U.S. TAVI Market-Average Selling Price of Implants by Company
Table 41: The U.S. TAVI Market-Average Selling Price of Implants by Company (2017-2022)
5.3 Outside the U.S.
5.3.1 OUS TAVI Market Share by Company
Table 42: OUS TAVI Market Share by Company (2017/2022)
5.3.2 OUS TAVI Market-Implanting Centers by Company
Table 43: OUS TAVI Market-Implanting Centers by Company (2017-2022)
5.3.3 OUS TAVI Market-Total Implants by Company
Table 44: OUS TAVI Market-Total Implants by Company (2017-2022)
5.3.4 OUS TAVI Market-Average Selling Price of Implants by Company
Table 45: OUS TAVI Market-Average Selling Price of Implants by Company (2017-2022)
6. Company Profiles
6.1 Edwards Lifesciences
6.1.1 Business Overview
Table 46: Edwards Lifesciences Corporation Revenue by Segments (2017)
6.1.2 Financial Overview
Table 47: Edwards Lifesciences Net Sales and Net Income (2013-2017)
6.1.3 Business Strategies
Table 48: Edwards Lifesciences R&D Expenditure (2015-2017)
6.2 Medtronic Plc.
6.2.1 Business Overview
Table 49: Medtronic Plc. Revenue by Segments (2017*)
6.2.2 Financial Overview
Table 50: Medtronic Plc. Net Sales and Net Income (2013-2017*)
6.2.3 Business Strategies
6.3 Boston Scientific
6.3.1 Business Overview
Table 51: Boston Scientific Revenue by Segments (2017)
6.3.2 Financial Overview
Table 52: Boston Scientific Revenue and Net Income (2013-2017)
6.3.3 Business Strategies
Table 53: Boston Scientific R&D Expenditure (2015-2017)
6.4 Abbott Laboratories
6.4.1 Business Overview
Table 54: Abbott Laboratories Revenue by Segments (2017)
6.4.2 Financial Overview
Table 55: Abbott Laboratories Net Sales and Net Earnings (2013-2017)
6.4.3 Business Strategies
Table 56: Abbott Laboratories R&D Expenditure (2015-2017)

$800
$1,100
 
Research assistance
US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks